On the Couch with Jason Segal (The Armchair Analyst): Drugs, Devices and Where the Risk Sits

In this episode of On the Couch , Henry Jennings speaks with Jason Segal , founder of The Armchair Analyst , a newsletter focused on ASX healthcare and life sciences stocks. They discuss where the risk sits for drug developers versus medical device businesses, how timing around clinical data readouts plays into share prices, and the weight Jason puts on management at smaller biotechs. He also covers external validation such as big pharma deals, cash burn as his biggest red flag, valuing companies that are years from making money, and the psychedelic medicine sector. — Marcus Today – Daily Market Insights Marcus Today provides clear, practical commentary for self-directed investors – covering markets, portfolios, education, and decision-making without the noise. If you'd like to go further: Start a free 14-day trial of Marcus Today https://marcustoday.com.au/trial-sign-up/?utm_source=podcast&utm_medium=audio&utm_campaign=free-trial Join Marcus Today Use code MTPODCAST for 10% off. https://marcustoday.com.au/sign-up/?pc=MTPODCAST&utm_source=podcast&utm_medium=audio&utm_campaign=sign-up MT20 – Managed ETF Portfolio A professionally managed portfolio run by Marcus Padley and the team, using ASX-listed ETFs with active market timing. https://marcustoday.com.au/managed-portfolios/?utm_source=podcast&utm_medium=audio&utm_campaign=mt20-info Principles – How We Think About Investing A short video series on timing, behaviour, and decision-making. No stock tips. https://marcustoday.com.au/mini-series-principles-sign-up/?utm_source=podcast&utm_medium=audio&utm_campaign=principles-mini-series — Disclaimer This podcast is general information only and does not consider your personal circumstances. It is not personal financial advice.